Buckinghamshire Healthcare NHS Trust

Thames Valley, Cancer Alliance

Management of High Grade Dysplasia patients

Time period: 2015-19
Cancer Alliance National
Number of High Grade Dysplasia patients in audit 69 1448
Cancer Alliance National
Method of Diagnosis
– First diagnosis confirmed by second pathologist 61 89.1% 86.9%
Treatment planning
– HGD plan discussed at MDT 62 89.9% 87.9%
– Treatment plan for active treatment 65 94.2% 81.1%
First treatment
– Endoscopic therapy (such as endoscopic resection) 60 87.0% 73.8%
– Surveillance 2 2.9% 11.0%

Management of oesophago-gastric cancer patients

Time period: 2017-2019
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit 128 20528
Case ascertainment for OG cancer (%) 85-100%
Method of Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
4 4.0% 13.3%
– Patients with referral source reported as unknown 1 0.8% 1.8%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded 125 97.7% 86.9%
Treatment planning
– Patients having a plan for curative treatment 48 37.5% 38.5%
– Patients having a plan for non-curative treatment 80 62.5% 61.5%
– Patients with non-curative plans having chemotherapy or radiotherapy 59 73.8% 48.2%

Download this data as a PDF